- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mankind Pharma's board has approved the acquisition of the Women Health Rx Portfolio, a branded generic business, from its wholly-owned subsidiary, Bharat Serums and Vaccines Ltd (BSV). This strategic move, structured as a slump sale for cash, integrates a prescription-driven business into Mankind's core strength. The acquisition aims to enhance operational, commercial, and financial efficiency by leveraging business synergies. The acquired segment reported a turnover of ₹103.67 Cr for FY25. The transaction is expected to conclude by September 30, 2025, with the final consideration determined at closing.